Sign in to view content

Race Representation in Diabetic Macular Edema Randomized Control Trials Compared to the United States Census Data

Abdul-Hadi Kaakour, MD, MS

Video
Published 2021

Related

Timing of Ocular Adverse Events in Pooled Analysis of Two Phase 3 Trials of Revakinagene Taroretcel (NT-501) in Macular Telangiectasia Type 2
Dean Eliott, MD
Annual Meeting Talks
2025
PRISM Phase 2b Clinical Trial Evaluating Intravitreal 4D-150 in Adults With Neovascular Age-Related Macular Degeneration: 52-Week Results
John A. Wells, MD, FACS
Updates from the Field
2025
Outcomes of DRCR Network Treatment Regimen Starting with Observation for Eyes With Center-involved Diabetic Macular Edema and Good Visual Acuity
Omar S. Punjabi, MD
Updates from the Field
2019

Category: Diabetic Retinopathy

See more